Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized blinded trial of freeze-dried ACYW135 meningococcal conjugate vaccine in infants
ChiCTR-PPR-15006591Phase 2Not yet recruiting
- Sponsor
- Hubei Center for Disease Control and Prevention
- Start
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of Meningococcal conjugate vaccine quadrivalent in meningococcal meningitis (5 arms), sponsored by Hubei Center for Disease Control and Prevention. Primary endpoints: Adverse reaction rate and Group-specific complement-mediated bactericidal antibody titers. Planned start Nov 2015; status: not yet recruiting.
02
Drugs
Meningococcal conjugate vaccine quadrivalent
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on ChiCTR-PPR-15006591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PPR-15006591.